SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-008855
Filing Date
2022-05-16
Accepted
2022-05-16 07:16:42
Documents
67
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q hook-20220331x10q.htm   iXBRL 10-Q 1258840
2 EX-31.1 hook-20220331xex31d1.htm EX-31.1 9853
3 EX-31.2 hook-20220331xex31d2.htm EX-31.2 9847
4 EX-32.1 hook-20220331xex32d1.htm EX-32.1 8330
  Complete submission text file 0001558370-22-008855.txt   5747186

Data Files

Seq Description Document Type Size
5 EX-101.SCH hook-20220331.xsd EX-101.SCH 52790
6 EX-101.CAL hook-20220331_cal.xml EX-101.CAL 52689
7 EX-101.DEF hook-20220331_def.xml EX-101.DEF 187252
8 EX-101.LAB hook-20220331_lab.xml EX-101.LAB 440634
9 EX-101.PRE hook-20220331_pre.xml EX-101.PRE 325065
61 EXTRACTED XBRL INSTANCE DOCUMENT hook-20220331x10q_htm.xml XML 850924
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38869 | Film No.: 22925427
SIC: 2834 Pharmaceutical Preparations